Marion Niessner

Title: Marion Niessner: Innovator in Antibody Detection

Introduction

Marion Niessner is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the detection of antibodies. With a total of 2 patents, her work has advanced the understanding and detection of p53 antibodies, which are crucial in cancer research.

Latest Patents

Niessner's latest patents focus on an innovative in vitro method for detecting anti-p53 antibodies in a sample. The method involves incubating a sample with a p53 capture antigen and a p53 detection antigen. This process forms a complex that includes the p53 capture antigen, the anti-p53 antibody, and the p53 detection antigen. By separating the formed complex from unbound detection antigen and measuring the complex via the detection antigen, the presence of the anti-p53 antibody in the sample can be accurately detected.

Career Highlights

Marion Niessner is currently employed at Roche Diagnostics Operations, Inc., where she continues to develop her groundbreaking methods. Her expertise in antibody detection has positioned her as a key figure in her field, contributing to advancements in diagnostic technologies.

Collaborations

Throughout her career, Niessner has collaborated with notable colleagues, including Herbert Andres and Johann Karl. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Marion Niessner's contributions to the field of antibody detection exemplify her dedication to advancing medical diagnostics. Her innovative methods and collaborations continue to impact the biotechnology industry positively.